CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced CEO Frank Reynolds will showcase InVivo’s most recent breakthroughs and provide a business update to potential investors during the 113th FSX (Financial Services Exchange) Conference set for October 26-29 at the Ritz Carlton in Coconut Grove, Fla.
